Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 78 (GPR78) is a member of the G protein-coupled receptor (GPCR) superfamily, characterized by seven transmembrane domains and the ability to transduce extracellular signals via coupling to heterotrimeric G proteins[3][5]. GPR78 is an orphan receptor, meaning that its endogenous ligand has not been identified. The receptor displays significant constitutive (basal, ligand-independent) activity, primarily coupling to the G(s)-alpha protein, which stimulates adenylate cyclase to increase intracellular cyclic AMP (cAMP)[3][5]. Evidence from genetic association studies suggests a possible involvement of GPR78 in susceptibility to neuropsychiatric disorders such as bipolar affective disorder and schizophrenia, as well as in gastric cancer risk, but its precise physiological function remains unclear[3]. There are known alternatively spliced transcript variants of the GPR78 gene[3]. No drugs are currently known to target GPR78 directly, and research continues to elucidate its biological and therapeutic significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 78 (GPR78).